Q1 2025 net product revenue of $137.8 million, representing 75% year-over-year growth -- ARCALYST 2025 expected net product revenue increased to $590 - $605 million -- KPL-387 ...

For clinical application of your trial results ... you will find a flow diagram template freely available for download.28 We suggest you add some additional information to the flow diagram, including ...

Regulatory delays could hinder Mind Medicine's patient access and market entry. Read why we are initiating coverage on MNMD ...

Eli Lilly benefits from rising cash flow and a strong pipeline, yet elevated pricing versus peers limits near-term gains. See why LLY is a hold.

First quarter 2025 revenues of $3.0 billion; GAAP diluted EPS of $7.27 and non-GAAP diluted EPS(a) of $8.22First quarter 2025 Dupixent® global net sales (recorded by Sanofi) increased 19% to $3.67 bil ...

Q1 2025 Earnings Call Transcript April 15, 2025 Johnson & Johnson beats earnings expectations. Reported EPS is $2.77, ...

Metabolic problems such as insulin resistance are linked to inflammation, oxidative stress, and altered blood flow ... of 26 clinical trials including data from 164,531 participants.

looking at the clinical trial flow chart and looking for preparation, implementation, regulatory, IRB, monitoring, data collection, and among those bricks we have went to lower bricks, and we have ...

It also includes rose hips extract and French maritime pine bark to help reduce inflammation and support blood flow to the vagina. A 2019 clinical trial ... by the company, participants taking ...

Every bottle listed ingredients I could actually pronounce, backed by clinical studies ... A 12-week placebo-controlled trial referenced in the American Brain Journal (fictional) concluded that ...

Presentation Operator Good morning, and welcome to Johnson Johnson's First Quarter 2025 Earnings Conference Call. [Operator ...